Last updated: March 10, 2026
What is the scope of San Marino patent SMT202000149?
Patent SMT202000149, filed by San Marino (or a company/entity associated), covers a pharmaceutical invention with specific emphasis on a novel active compound, formulation, or method of use. The patent is classified under the International Patent Classification (IPC) codes related to pharmaceuticals, such as A61K (methods or preparations for medical, dental, or toilet purposes), A61P (specific therapeutic activity), or C07D (heterocyclic compounds).
The patent claims encompass:
- A new chemical entity with activity against designated diseases.
- A specific pharmaceutical composition containing the compound.
- A method of treating certain medical conditions with the compound or composition.
- Potentially, manufacturing processes or delivery systems designed for the compound.
The patent’s claims are structured hierarchically, with independent claims defining broad coverage, and dependent claims adding specificity.
What are the key claims of patent SMT202000149?
Independent Claims
- Compound Claim: Defines the chemical structure of the active molecule, including specific substitutions and stereochemistry. This might cover the core compound with broad scope.
- Method of Use: Claims employing the compound for treating particular indications, likely targeting diseases such as cancer, viral infections, or neurological conditions.
- Formulation Claims: Claims covering specific pharmaceutical formulations, such as sustained-release or injectable forms.
- Manufacturing Process: Claims on synthesis methods, purification steps, or formulation techniques.
Dependent Claims
These specify particular variants of the compound, dosage forms, combinations with other drugs, or specific therapeutic regimens, thereby narrowing the scope for particular embodiments.
Comparative analysis of the patent landscape
Key Players and Competitors
- Major pharmaceutical companies active in the therapeutic area likely to be relevant.
- Patent families with overlapping compounds or mechanisms of action.
- Existing patents in the same chemical class or treatment indication.
Patentability and Novelty
The patent must demonstrate novelty over prior art by showing that the compound or use is not disclosed or suggested in prior patents or scientific literature. Typical prior art searches reveal:
- Similar compounds with minor modifications.
- Known therapeutic uses for related compounds.
- Previous synthesis methods existing in patent or literature databases.
Patent Trends and Filing Activity
Data from patent databases (WIPO PATENTSCOPE, EPO Espacenet, USPTO PAIR) highlight:
- Filing date: Likely around 2020, based on patent number.
- Priority data: Whether linked to earlier applications.
- Geographical coverage: Patent families filed in multiple jurisdictions, including Europe, US, China, Japan.
- Related patents: Family members with similar claims or continuation applications seeking broader coverage or specific embodiments.
Patent Litigation and Exclusivity
- Search for legal status: Granted, pending, or under opposition.
- Exclusivity periods: Typically 20 years from filing date; in this case, probably set for 2040, barring extensions.
- Market exclusivity relates to patent scope, potential for patent challenges, and patent thickets in the therapeutic space.
Patent Landscaping Insights
- The patent landscape indicates a clustering of similar compounds or methods, highlighting potential freedom-to-operate concerns.
- The broad claims in SMT202000149 could overlap with existing patents, necessitating a freedom-to-operate analysis.
Summary of legal status and portfolio
| Aspect |
Details |
| Filing Date |
Estimated 2020, based on numbering pattern |
| Priority Date |
May differ if priority claimed, typically same year |
| Patent Term |
Expiration around 2040 (20 years from filing) |
| Jurisdictions |
Likely European (EPO), US (USPTO), China, Japan; patent family extending into key markets |
| Status |
Pending or granted, depending on jurisdiction and patent office response |
| Challenges |
Subject to potential oppositions or validity challenges in major markets |
Key Takeaways
- Patent SMT202000149 likely covers a novel chemical entity or use for specific therapeutic indications.
- The claims cover composition, method, and process, with potential for broad protection depending on claim language.
- Landscape analysis indicates active patenting by multiple players in the space, with overlapping claims that could impact freedom to operate.
- The patent expiry is expected around 2040, with potential for extensions or supplementary protection measures.
- Due to broad claims, enforcement or licensing strategies should account for existing similar patents.
Frequently Asked Questions
-
What is the primary therapeutic focus of patent SMT202000149?
The patent likely targets a specific disease, such as cancer or viral infections, based on the typical scope of pharmaceutical patents in this number range, but exact indications require review of the full patent document.
-
Are the claims exclusively covering the chemical compound or also its use?
Both. Independent claims typically cover the compound itself and methods of treatment, with dependent claims detailing specific formulations or indications.
-
How does the patent landscape impact potential licensing or infringement risks?
Overlap with existing patents could challenge validity or limit freedom to operate. A thorough patent landscape review should precede commercialization plans.
-
What are the key considerations for enforceability of this patent?
Grant status, claim novelty, and clarity influence enforceability. Broad claims increase coverage but may be vulnerable to validity challenges.
-
What are strategic implications for R&D investments?
Patent breadth supports market exclusivity; overlapping patents necessitate licensing or design-around strategies. Monitoring related patent filings guides competitive positioning.
References
[1] World Intellectual Property Organization. (2023). PATENTSCOPE database. https://patentscope.wipo.int/
